Time for arginine methylation: PRMT5 inhibition to advance cholangiocarcinoma treatment
Gut
.
2024 Dec 6:gutjnl-2024-333632.
doi: 10.1136/gutjnl-2024-333632.
Online ahead of print.
Authors
Romain Désert
1
,
Lipika Goyal
2
,
Thomas F Baumert
3
4
Affiliations
1
University of Strasbourg, Inserm, Institute for Translational Medicine and Liver Disease (ITM), UMR_S1110, Strasbourg, France.
2
Division of Oncology, Department of Medicine, Stanford School of Medicine, Palo Alto, California, USA.
3
University of Strasbourg, Inserm, Institute for Translational Medicine and Liver Disease (ITM), UMR_S1110, Strasbourg, France
[email protected]
.
4
Gastroenterologie-Hepatology Service, Strasbourg University Hospitals, Strasbourg, France.
PMID:
39642967
DOI:
10.1136/gutjnl-2024-333632
No abstract available
Keywords:
CHOLANGIOCARCINOMA; GENE TARGETING.